Novo cuts prices in US and launches Wegovy introductory offer

Novo Nordisk has announced a price reduction for the weight-loss medication Wegovy and the diabetes drug Ozempic in the US for self-paying patients. New patients can purchase the lowest dose for $199 per month until March 31, 2026, equal to approximately 1,280 DKK. After the initial two months,...